← 產業報告目錄
Molecular Cytogenetics Market Size, Share & Trends Analysis Distribution by Product (Kits & Reagents, Instruments, Consumables, Software & Services), Technique (Comparative Genomic Hybridization, Fluorescence In-Situ Hybridization, Chromogenic In-Situ Hybridization, Other Techniques), Application, End User and Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-24頁數 172報告編號 INSIGHTACE-23c5bb1cd9
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Molecular Cytogenetics Market stood at USD 3.13 Bn in 2023, and is anticipated to reach USD 6.72 Bn by 2031, recording a CAGR of 10.4% from 2024 through 2031.
At its core, Molecular Cytogenetics pertains to landscape are growingly turning to these solutions to meet contemporary demands.
Growth is propelled by a convergence of factors: rising awareness among end users, continuous product innovation, and the growing emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region anticipated to deliver the strongest growth trajectory through the forecast period, propelled by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Molecular Cytogenetics Market Snapshot
Chapter 4. Global Molecular Cytogenetics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Molecular Cytogenetics Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Molecular Cytogenetics Industry Trends
Chapter 5. Molecular Cytogenetics Market Segmentation 1: By Product, Estimates & Trend Analysis
5.1. Market Share by Product, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Product:
5.2.1. Kits & Reagents
5.2.1.1. Testing Kits
5.2.1.2. Probes
5.2.1.3. Fluorescent Affinity Reagents
5.2.1.4. Other Kits & Reagents
5.2.2. Instruments
5.2.3. Consumables
5.2.4. Software & Services
Chapter 6. Molecular Cytogenetics Market Segmentation 2: By Technique, Estimates & Trend Analysis
6.1. Market Share by Technique, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Technique:
6.2.1. Comparative Genomic Hybridization
6.2.1.1. Array-Based Comparative Genomic Hybridization
6.2.1.2. Standard Comparative Genomic Hybridization
6.2.2. Fluorescence In-Situ Hybridization
6.2.3. Chromogenic In-Situ Hybridization
6.2.4. Other Techniques
Chapter 7. Molecular Cytogenetics Market Segmentation 3: By Application, Estimates & Trend Analysis
7.1. Market Share by Application, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Application:
7.2.1. Genetic Disorders
7.2.2. Cancer
7.2.3. Personalized Medicine
7.2.4. Other Applications
Chapter 8. Molecular Cytogenetics Market Segmentation 4: By End-User, Estimates & Trend Analysis
8.1. Market Share by End-User, 2023 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End-User:
8.2.1. Clinical & Research Laboratories
8.2.2. Academic Research Institutes
8.2.3. Pharmaceutical & Biotechnology Companies
8.2.4. Other End Users
Chapter 9. Molecular Cytogenetics Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Molecular Cytogenetics Market, Regional Snapshot 2023 & 2031
9.2. North America
9.2.1. North America Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.2.3. North America Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2024-2031
9.2.4. North America Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.2.5. North America Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
9.3. Europe
9.3.1. Europe Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.3.3. Europe Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2024-2031
9.3.4. Europe Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.3.5. Europe Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
9.4. Asia Pacific
9.4.1. Asia Pacific Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.4.3. Asia Pacific Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2024-2031
9.4.4. Asia Pacific Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts By Application, 2024-2031
9.4.5. Asia Pacific Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
9.5. Latin America
9.5.1. Latin America Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.5.3. Latin America Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2024-2031
9.5.4. Latin America Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.5.5. Latin America Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
9.6. Middle East & Africa
9.6.1. Middle East & Africa Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
9.6.3. Middle East & Africa Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2024-2031
9.6.4. Middle East & Africa Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.6.5. Middle East & Africa Molecular Cytogenetics Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Dentsply Sirona, Inc.
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service Offerings
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. F. Hoffmann-La Roche Ltd.
10.2.3. Danaher Corporation
10.2.4. Agilent Technologies, Inc.
10.2.5. Abbott Laboratories
10.2.6. Thermo Fisher Scientific, Inc.
10.2.7. Illumina Inc.
10.2.8. Revvity
10.2.9. Pacific Biosciences
10.2.10. Bio-Rad Laboratories, Inc.
10.2.11. Bio-Techne Corporation
10.2.12. Genedx
10.2.13. Oncocyte Corporation
10.2.14. Bioview
10.2.15. Other Prominent Players
10.2.15.1. Oxford Gene Technology Ip Limited (Part of Sysmex)
10.2.15.2. Applied Spectral Imaging, Inc.
10.2.15.3. Cytotest Inc.
10.2.15.4. Chromatids, Inc.
10.2.15.5. Genial Genetic Solutions Ltd.
10.2.15.6. Cytognomix, Inc.
10.2.15.7. Metasystems
10.2.15.8. Scigene
10.2.15.9. Biomodal
10.2.15.10. Biocare Medical
10.2.15.11. Biodot
10.2.15.12. Oncodna
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們